[Elsevier] LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial |
|
This post will be closed automatically in 2026-08-28 18:26
Best Answer
Half hour(s) ago
|
| |
post
reply
points
17850
10
Performance-based wind and earthquake design framework for tall steel buildings with ductile detailing
10
Efficacy of botulinum toxin for masseter muscle hypertrophy: A systematic review and meta-analysis
10
Effects of wheatgrass powder on the rheology, microstructure, and functional chemistry of 3D-printed sprouted finger millet meat analogues
10
Efficient fabrication of large-scale chalcogenide glass microlens arrays via precision molding method
10
Ultrasound protocols for measuring masseter muscle
